Cancer Imaging

Official Journal of ICIS

Peer-reviewed journal published by BioMed Central
Impact Factor
0
5 Year Impact Factor
0
To First Decision
0 Days
Downloads (2023)
0 +
Impact Factor
0
5 Year Impact Factor
0
To First Decision
0 Days
Downloads (2023)
0 +
Cancer Imaging, the official journal of ICIS, is a leading open-access, peer-reviewed journal published by BioMed Central. With a newly released Impact Factor of 3.5, Cancer Imaging ranks in the top quartile of all imaging journals, reflecting its commitment to high-quality scientific research.
Submit Manuscript
2024 Abstract Supplement
Read Our Articles
Submit Manuscript
2024 Abstract Supplement
Read Our Articles

Cancer Imaging, the official journal of ICIS, is a leading open-access, peer-reviewed journal published by BioMed Central. With a newly released Impact Factor of 3.5, Cancer Imaging ranks in the top quartile of all imaging journals, reflecting its commitment to high-quality scientific research.

The journal regularly publishes original articles, reviews and editorials from international imaging experts, with a particular focus on oncology. Readers can stay informed by signing up for alerts to receive the latest cutting-edge content, including studies encompassing CT, MRI, ultrasound, single photon positron emission tomography, and multimodality imaging in malignant tumours, as well as new developments, techniques and innovations.

All articles are indexed in major biomedical bibliographic databases such as PubMed, Embase, EmCare, Google Scholar, MEDLINE, Science Citation Index, and Scopus. Full texts are also available via PubMed Central, the U.S. National Library of Medicine’s repository for life sciences literature.

Editorial Board

The Cancer Imaging Editorial Board is led by Editor-in-Chief, Professor Khaled Elsayes, MD (MD Anderson Cancer Centre, USA), supported by Deputy Editors Dr Katherine Krajewski, MD (Dana-Farber Cancer Institute, USA), Dr Elaine Lee, MD (University of Hong Kong, China), Professor Olivier Lucidarme, MD, PhD (Pitié-Salpêtrière University Hospital, France) and Prof. Dr. med. Thorsten Persigehl (University Hospital Cologne, Germany).
An international collection of experts act as Section Editors covering all the sub-specialty areas of oncological imaging.

Reznek Prize

Named after Professor Rodney Reznek, the founding editor of the journal, the Reznek Prize is awarded every year to the authors of the article to receive the most citations.

The 2024 Reznek Prize was awarded to Dr. Dong He et al. for their article “MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins” Published in 2021, the paper has received 36 citations so far. Congratulations to Dr. He and all co-authors!

Support the journal

ICIS members can support the society’s journal in a number of ways:
  • Submit your next manuscript to Cancer Imaging and receive a 20% discount on the article-processing fee.
  • Volunteer to become a reviewer. If you have expertise in a particular area and would like to help the journal by reviewing articles, email us at [email protected]
  • Join the Editorial Board and help to the shape the future direction of Cancer Imaging. Our email is [email protected]

For full details of the journal’s submission guidelines, peer-review and editorial policy see

www.cancerimagingjournal.biomedcentral.com
Scroll to Top